AMRN Q4 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$143M+85.3% YoY

Gross Profit

$113M78.6% margin

Operating Income

$5M3.8% margin

Net Income

$7M4.9% margin

EPS (Diluted)

$0.40

QoQ Revenue Growth

+27.5%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$882M

Total Liabilities

$274M

Stockholders' Equity

$608M

Cash & Equivalents

$645M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$143M	$77M	+85.3%
Gross Profit	$113M	$60M	+88.2%
Operating Income	$5M	-$32M	+117.3%
Net Income	$7M	-$34M	+121.0%

Revenue Segments

Product

$142M99%

License

$1M1%